DekaBank Deutsche Girozentrale
HCAT icon

DekaBank Deutsche Girozentrale’s Health Catalyst HCAT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,350
Closed -$132K – 1380
2021
Q4 		$132K Hold
3,350
– – ﹤0.01% 1316
2021
Q3 		$168K Hold
3,350
– – ﹤0.01% 1235
2021
Q2 		$187K Hold
3,350
– – ﹤0.01% 1231
2021
Q1 		$155K Buy
+3,350
New +$162K ﹤0.01% 1233

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

DekaBank Deutsche Girozentrale's HCAT Position: Q1 2022 in Review

DekaBank Deutsche Girozentrale sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 3,350 shares — an estimated $132K sold.

DekaBank Deutsche Girozentrale first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $187K in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 3,350 Health Catalyst shares in Q1 2022, an estimated $132K.
  • DekaBank Deutsche Girozentrale first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Health Catalyst position peaked at $187K in Q2 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2022, filed 28 Apr 2022.